Alnylam Pharmace. buy Chardan Capital
Summary
This prediction ended on 09.08.24 with a price of €247.10. With a performance of 46.56% the BUY prediction by Chardan_Capital was a big success. Chardan_Capital has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Chardan_Capital has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 2.181% | 2.181% | -13.661% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Chardan_Capital for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
25.03.26
25.03.27
22:25
Stopped prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
02.05.25
02.05.26
03.05.26
Alnylam Pharmace.
26.02.25
26.02.26
27.02.26
Alnylam Pharmace.
11.10.24
11.10.25
12.10.25
Alnylam Pharmace.
16.02.24
16.02.25
17.02.25

